UPST:NASDAQUpstart Holdings, Inc. Analysis
Data as of 2026-06-16 - not real-time
$32.24
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Upstart (UPST) is trading at $32.24, comfortably above its 20‑day ($30.99) and 50‑day ($30.74) simple moving averages but still well under the 200‑day average ($40.58), indicating a short‑term bullish bias within a longer‑term downtrend. The RSI sits at 54.6, suggesting neutral momentum, while the MACD remains bullish with a modest histogram (+0.07). Volatility is exceptionally high at 71.6% over the past 30 days and beta exceeds 2.8, underscoring pronounced price swings and market sensitivity. Fundamentally, revenue surged 44.6% YoY to $1.17 B with an impressive 82.7% gross margin, yet operating cash flow and free cash flow are negative, and the debt‑to‑equity ratio is a staggering 269, flagging balance‑sheet strain. Valuation metrics are mixed: the trailing P/E of 78.6 dwarfs the industry average of 17.1, but a forward P/E of 9.4 hints at substantial earnings upside. The stock faces acute legal headwinds, with multiple securities‑fraud class actions alleging AI model mis‑calibration and a sharp decline in conversion rates, adding regulatory and reputational risk.
Given the technical support around $26.77 and resistance near $34.69, the price is perched midway, offering limited upside unless the litigation resolves favorably and cash‑flow improvements materialize. The high growth profile and forward earnings potential support a longer‑term view, but the current overvaluation, debt burden, and extreme market sentiment (Fear & Greed Index at "Extreme Greed") suggest caution for near‑term investors.
Given the technical support around $26.77 and resistance near $34.69, the price is perched midway, offering limited upside unless the litigation resolves favorably and cash‑flow improvements materialize. The high growth profile and forward earnings potential support a longer‑term view, but the current overvaluation, debt burden, and extreme market sentiment (Fear & Greed Index at "Extreme Greed") suggest caution for near‑term investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Pending securities‑fraud class actions increasing legal uncertainty
- High short‑term volatility and beta
- Price near resistance with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth and high gross margins
- Forward P/E compression suggesting earnings improvement
- Ongoing legal resolution risk
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- AI‑driven lending platform with scalable growth potential
- Undervalued forward earnings multiple
- Potential balance‑sheet deleveraging if cash‑flow turns positive
Key Metrics & Analysis
Financial Health
Revenue Growth44.60%
Profit Margin4.21%
P/E Ratio78.6
ROE7.01%
ROA1.77%
Debt/Equity269.84
P/B Ratio4.2
Op. Cash Flow$-267536000
Free Cash Flow$-312582368
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI54.6
Support$26.77
Resistance$34.69
MA 20$30.99
MA 50$30.74
MA 200$40.58
MACDBullish
VolumeStable
Fear & Greed Index92.13
Valuation
Target Price$40.13
Upside/Downside24.48%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.84
Volatility71.64%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.